ArticleIndian journal of ophthalmology2026
Antibiotic resistance patterns of methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus isolates in keratitis: Insights from an 11-year analysis.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the prevalence and antibiotic resistance trends in methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) keratitis over an 11-year study period.
designRetrospective study.
methodsMicrobiology records of patients with culture-positive Staphylococcus aureus (SA) keratitis presenting to a tertiary eye center over 11 years were retrospectively reviewed. Susceptibility data to commonly used topical antibiotics were obtained.
resultsMSSA accounted for 58.4% of SA keratitis, while MRSA constituted 41.6%. No significant change in prevalence was observed for MRSA or MSSA keratitis over the study period. Both MSSA and MRSA had a higher proportion of isolates resistant to antibiotics in the fluoroquinolone group, compared to chloramphenicol, cefazolin, and vancomycin. A greater proportion of MRSA isolates were resistant to cefazolin (15.4%) compared to MSSA (0.5%). Almost all isolates were susceptible to vancomycin, except an isolated MRSA case in 2022. There was no significant increase in the proportion of MSSA and MRSA isolates resistant to antibiotics, except for the proportion of MSSA isolates resistant to chloramphenicol ( R2= 0.81), and MRSA isolates to cefazolin ( R2= 0.74).
conclusionNo significant increase in the prevalence of MRSA keratitis over the study period was observed. A high proportion of resistance of MSSA isolates to commonly used topical antibiotics challenges the conventional notion that MRSA is more resistant to antibiotics than MSSA. The observed proportion of SA isolates resistant to fluoroquinolones and the increasing percentage of isolates resistant to cefazolin emphasize the need for continued surveillance to strategize empirical treatment policies. Minimal resistance to vancomycin supports its continued use as a reserve drug in cases of severe multi-drug resistant SA keratitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.